Yi Li
About Yi Li
Yi Li is a Director at Brii Biosciences in Durham, North Carolina, with over 12 years of experience in clinical research management, particularly in the Asia-Pacific region. He has held various project management roles across multiple therapeutic areas and has worked with several prominent organizations in the field.
Work at Brii Biosciences
Yi Li has served as Director at Brii Biosciences since 2018. Located in Durham, North Carolina, the company focuses on developing innovative therapies for infectious diseases. In this role, Yi Li oversees various projects and initiatives, leveraging extensive experience in clinical research management.
Current Role at Takeda Pharmaceuticals
Yi Li currently holds the position of Senior Clinical Study Manager at Takeda Pharmaceuticals in Tokyo, Japan, a role he has occupied since 2017. He has previously worked as a Clinical Study Manager at Takeda Pharmaceuticals Asia Pacific in Singapore since 2014. His responsibilities include managing clinical studies and ensuring compliance with regulatory requirements.
Previous Experience in Clinical Research
Before joining Brii Biosciences, Yi Li worked at Covance as a Project Manager from 2012 to 2014 in Princeton, New Jersey. He also served as a Clinical Trial Manager at Icon Plc from 2010 to 2012 in Leopardstown, Dublin, Ireland. Additionally, he held a position as Clinical Affairs Project Manager at GE Healthcare for six months in 2014 in Chicago, Illinois.
Expertise in Clinical Research Management
Yi Li has over 12 years of experience in clinical research management, with a specific focus on the Asia-Pacific region. His expertise encompasses managing clinical research projects across various therapeutic areas, including Oncology, Respiratory, Psychiatry, Women's Health, and Phase I studies. He has accumulated eight years of experience in project management roles within the clinical research field.